1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies

Endologix Inc (ELGX) Files 10-K for the Fiscal Year Ended on December 31, 2018

April 01, 2019 | About:

Endologix Inc (NASDAQ:ELGX) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Endologix Inc develops, manufactures, markets and sells medical devices for the treatment of aortic disorders. Its products are intended for the treatment of abdominal aortic aneurysms. Endologix Inc has a market cap of $68.383 million; its shares were traded at around $6.61 with and P/S ratio of 0.34.

For the last quarter Endologix Inc reported a revenue of $34.7 million, compared with the revenue of $44.00 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $156.5 million, a decrease of 13.6% from the previous year. For the last five years Endologix Inc had an average revenue growth rate of 4.9% a year.

The reported loss per diluted share was $9.1 for the year, compared with the loss per share of $7.5 in the previous year. The Endologix Inc had an operating margin of -40.3%, compared with the operating margin of -22.27% a year before. The 10-year historical median operating margin of Endologix Inc is -19.88%. The profitability rank of the company is 4 (out of 10).

At the end of the fiscal year, Endologix Inc has the cash and cash equivalents of $23.5 million, compared with $58.0 million in the previous year. The long term debt was $198.1 million, compared with $208.3 million in the previous year. Endologix Inc has a financial strength rank of 3 (out of 10).

At the current stock price of $6.61, Endologix Inc is traded at 92.9% discount to its historical median P/S valuation band of $92.73. The P/S ratio of the stock is 0.34, while the historical median P/S ratio is 4.71. The stock lost 84.37% during the past 12 months.

For the complete 20-year historical financial data of ELGX, click here.

Rating: 0.0/5 (0 votes)


Please leave your comment:

Performances of the stocks mentioned by insider

User Generated Screeners

pascal.van.garsseHigh FCF-M2
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
/* */